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and Radiation Therapy: A Case Report
Daniel Ikeda, James S. Harrop MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 
Introduction 
Intramedullary spinal cord metastases (ISCM) are a clinically rare, although devastating, complication 
of disseminated cancer. These lesions have been reported to originate from many types of solid 
tumors, although primary lung carcinoma, particularly small cell, is the most common etiology. 
These metastases, which can occur anywhere along the spinal cord, often represent the end-stage of 
the disease process with limited survival outcomes.
Patients with ISCM may develop a variety of neurological deficits with treatment goals aimed at 
palliation.  Different modalities of treatment have been found to preserve or restore ambulation and 
neurological function. The options for therapeutic intervention include surgical, chemotherapeutic, 
and radiation therapy. We describe a case of ISCM in a patient with disseminated small cell lung 
cancer with magnetic resonance imaging that illustrates a complete tumor response to radiation 
therapy
Case Report
In December of 2006, a 63 year-old male presented with extensive stage small cell lung carcinoma. 
Upon initial presentation, this patient had a very large, left pulmonary mass, mediastinal lymph-
adenopathy, multiple hepatic lesions, and several osseous lesions. Due to the extent of his disease, 
the patient was referred to medical oncology and treated with chemotherapy. A PET scan on July of 
2007 revealed radiographic resolution of his malignancy following his chemotherapy. On October 
3rd of 2007, after presenting with dizziness, it was found he had metastasis to his cerebellar vermis. 
These metastases were treated with 30 Gy of whole brain radiation therapy and his vertigo signifi-
cantly improved. A follow-up brain MRI showed a complete response to treatment with no residual 
metastases found. 
In December of 2007, the patient presented with bilateral shoulder and neck pain. The pain started 
in his right shoulder radiating to his mid neck and then to his left shoulder.  The pain had been 
intermittent, but intense, over the previous few weeks and progressed to right arm numbness. There 
was no associated muscle weakness in his upper or lower extremities bilaterally. The patient displayed 
some mild right hand intrinsic weakness; deep tendon reflexes were found to be slightly increased 
in his lower extremities versus his upper extremities.  An open MRI with and without IV contrast 
of the cervical spine was performed. A contrast enhancing mass within the cervical spinal cord was 
noted and reported as an ependymoma, due to the infrequency of intraparenchymal metastasis. To 
get better definition of the lesion, a repeat closed high-resolution MRI of the cervical, thoracic, and 
lumbar spine was performed. The cervical contrast enhancing lesion was found to be three separate 
intramedullary multifocal with measured total length of 4.5 cm (Figure 1A). There were no other 
lesions in the spinal cord. The presence of three distinct lesions in the setting of metastatic disease was 
consistent with multiple intraparenchymal metastatic disease rather than a primary intramedullary 
neoplasm (ependymoma).
The patient’s disease was in remission and 30 Gy of cervical spine radiation was administered. The 
patient reported that his symptoms of pain and numbness resolved completely with the radiation 
therapy.  
A follow-up MRI demonstrated a complete response and no evidence of the ISCM lesion (Figure 1B).  
Discussion
Although rarely reported, ISCM have been found in 0.9% to 2.1% of cancer patients by autopsy, 
suggesting that thousands of patients are afflicted yearly1. Primary lung carcinoma is the most com-
mon etiology and reported to occur in up to fifty percent of cases of ISCM2.  In one retrospective 
study, small cell lung cancer was the most com-
mon primary tumor in patients with ISCM, 
accounting for 63% of patients with primary 
lung cancer and 30% of all patients studied2. 
However, other solid tumors, including breast, 
kidney, colorectal, cervical, and ovarian cancers 
have also been reported3,4,5.  
A variety of neurological disorders charac-
terizes the presenting symptoms of ISCM 
clinically. Schiff and O’Neill reported sensory 
alteration (42.5%), pain (30%), and weakness 
(30%) as the most common initial symptoms2. 
Figure 1A
Cervical MRI, prior to 30 Gy radiotherapy
Figure 1B
Cervical MRI, post radiotherap
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The symptoms of gait unsteadiness, urinary 
incontinence, and Brown-Sequard syndrome 
have also been described2,6.  
Diagnosis of ISCM usually requires magnetic 
resonance imaging (MRI) or computerized 
tomography (CT), because plane films and 
myelography are normal in 75% and 58% of 
cases7. In addition, cerebral spinal fluid (CSF) 
analysis is often non-diagnostic with the 
most common abnormal finding of elevated 
protein in only 20% of cases8. Computerize 
tomography scanning has been found to be 
diagnostic in few patients, which is demon-
strated by increased density in the area of the 
ISCM lesions.  However, magnetic resonance 
imaging (MRI) has greater sensitivity and 
specificity7. MRI T2-weighted images show 
alterations in signal intensity based on tissue 
type and demonstrate accurate differentiation 
between normal tissue of the spinal cord and 
tumor  7.  Gadolinium is a helpful adjunct to the 
T2-weighted imaging as it reveals the enhancing 
central lesion in typical ISCM7. In a study of 30 
patients, there was only one false-negative MRI 
study, and 23 of 25 patients receiving gadolinium 
demonstrated contrast enhancement of ISCM 
lesions on MRI 2.
Treatment is generally palliative, as the median 
survival ranges from 3.9 to 5 months2,9,10.  Schiff 
and O’Neill found that patients with breast 
cancer as their primary tumor had the greatest 
median survival, which still was only 13 months. 
Patients with other primary cancers including 
lung carcinoma had a median survival of 3 
months. As with our patient, surgery is often 
contraindicated at the time of presentation, 
making the less invasive modalities of chemo-
therapy and radiation therapy the mainstays 
of treatment2,5,11. Radiation therapy has been 
shown to improve or prevent deterioration 
of neurological status. In Conill et al., they 
reported improvement of neurological symp-
toms in 83% of patients with a mean duration 
of 17.2 days. And Schiff and O’Neill reported 
preservation of ambulation in 91% of patients 
at their latest follow-up.  
Conclusions  
This case illustrates a rare complication of 
systemic small cell lung cancer. The ISCM lesion 
showed a rare complete response to radiation 
therapy, which was evidenced by magnetic 
resonance imaging and outlines the importance 
of radiation therapy in the treatment algorithm 
of these patients.
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